HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid - AJMC.com Managed Markets Network

Submitted by Anonymous (not verified) on Thu, 02/28/2019 - 17:43

HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid  AJMC.com Managed Markets NetworkBetween 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs ...